2018 Pan Pacific Lymphoma Conference

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

2018 Pan Pacific Lymphoma Conference

Bench to Bedside
Novel Therapies in Lymphoma
High Grade B-cell Lymphoma
Aggressive T-Cell Lymphoma
Hodgkin Lymphoma
Multiple Myeloma/Plasma Cell Dyscrasia
Common Indolent Lymphoma
Uncommon Indolent Lymphoma
Interprofessional Educational Day

Playback speed

10 seconds

Hodgkin Lymphoma: First Relapse Options

By 2018 Pan Pacific Lymphoma Conference FEATURING Barbara Pro

0 views

January 10, 2019

Comments 0

Evaluation, Diagnosis, Prognostication, and Emerging Therapies for M…

Feat. A. Tefferi

Current Approaches in the Treatment of Myeloproliferative Neoplasms

Feat. A. Tefferi

Hodgkin Lymphoma

20:26

2018 Pan Pacific Lymphoma Conference

Radiation Therapy for nondular lymphocyte predominant Hodgkin Lympho…

Feat. R. Hoppe

10:00

2018 Pan Pacific Lymphoma Conference

Relapsed and Primary Refractory Hodgkin Lymphoma in the Near Future

Feat. C. Moskowitz

15:48

2018 Pan Pacific Lymphoma Conference

Evalutation of patients for ASCT in Relapsed Refractory Hodgkin Lymp…

Feat. C. Moskowitz

21:11

2018 Pan Pacific Lymphoma Conference

Use of Total Metabolic Tumor Volume in PET Scans

Feat. N. Hansen

06:45

2018 Pan Pacific Lymphoma Conference

Hodgkin Lymphoma: First Relapse Options

Feat. B. Pro

16:04

2018 Pan Pacific Lymphoma Conference

Beyond Standard Chemotherapy Novel Agents and Appraoches in HL

Feat. B. Pro

20:54

2018 Pan Pacific Lymphoma Conference

Beyond Checkpoint Inhibitors for Hodgkin Lymphoma

Feat. S. Ansell

14:48

2018 Pan Pacific Lymphoma Conference

Hodgkin Lymphoma German Hodgkin Study Group Upfront Therapy

Feat. A. Engert